An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
NCT ID: NCT01508130
Last Updated: 2017-04-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
672 participants
OBSERVATIONAL
2012-01-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C
NCT01591460
A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
NCT01185860
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C
NCT01659567
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
NCT00758043
A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis
NCT01749150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic hepatitis C, genotype 1
* Receiving pegylated interferon-based direct acting antiviral therapy (pegylated interferon and ribavirin plus either telaprevir or boceprivir) in accordance with local standard of care and US labeling
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cooper Green Hospital
Birmingham, Alabama, United States
Univ. of Alabama at Birmingham; The Kirklin Clinic
Birmingham, Alabama, United States
Liver Wellness Center
Little Rock, Arkansas, United States
Loma Linda University Medical Center and Liver Center
Loma Linda, California, United States
HMRI Liver Center
Pasadena, California, United States
Kaiser Permanente San Diego; Hepatology Research
San Diego, California, United States
VA San Diego Healthcare System
San Diego, California, United States
South Bay Gastroenterology Medical Group
Torrance, California, United States
University of Colorado Denver
Aurora, Colorado, United States
Litchfield County Gastroenterology Associates
Torrington, Connecticut, United States
Consultive Medicine
Daytona Beach, Florida, United States
Florida Center for Gastroenterology
Largo, Florida, United States
Center for Advanced Gastroenterology
Maitland, Florida, United States
Internal Medicine Specialists
Orlando, Florida, United States
Orlando Infectious Disease Center, Pa
Orlando, Florida, United States
Tampa General Hospital; Tampa General Medical Group
Tampa, Florida, United States
Atlanta Center for Gastroenterology, PC
Decatur, Georgia, United States
Dekalb Gastroenterology Associates
Decatur, Georgia, United States
Gastroenterology Associates of Central Georgia
Macon, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Indianapolis Gastroenterology
Indianapolis, Indiana, United States
Tristate Gastroenerology Associates
Crestview Hills, Kentucky, United States
Ochsner Clinic Foundation
Baton Rouge, Louisiana, United States
New Orleans Research Institute.
Metairie, Louisiana, United States
Tulane Uni Health Sciences Center
New Orleans, Louisiana, United States
Mercy Medical Center; Institute For Digestive Health And Liver Disease
Baltimore, Maryland, United States
Commonwealth Clinical Studies
Brockton, Massachusetts, United States
Baystate Infectious Diseases Clinical Research
Springfield, Massachusetts, United States
Partners in Internal Medicine
Worcester, Massachusetts, United States
Harper University Hospital/Wayne State
Detroit, Michigan, United States
Gastroenterology Associates of Western Michigan
Wyoming, Michigan, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
St. Luke's Hospital
Kansas City, Missouri, United States
Midwest Biomedical Research Foundation
Kansas City, Missouri, United States
Saint Louis University Gastroenterology & Hepatology; Clinical Research Unit
St Louis, Missouri, United States
Dartmouth Hitchcock Med Center
Lebanon, New Hampshire, United States
Lourdes Medical Associates; Southern New Jersey Center for LIver Disease
Haddon Heights, New Jersey, United States
Atlantic Research Affiliates
Morristown, New Jersey, United States
AGA Clinical Research Associates, LLC
Twp, New Jersey, United States
New York Methodist Hospital
Brooklyn, New York, United States
Mountainview Medical Practice
Catskill, New York, United States
New Discovery, LLC
Flushing, New York, United States
North Shore University Hospital
Manhasset, New York, United States
Concorde Medical Group
New York, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Asheville Gastroenterology Associates, P.A.
Asheville, North Carolina, United States
Duke Univ Medical Center
Durham, North Carolina, United States
Boice-Willis Clinic
Rocky Mount, North Carolina, United States
INTEGRIS Baptist Medical Center
Oklahoma City, Oklahoma, United States
Bend Memorial Clinic
Bend, Oregon, United States
DuBois Regional Medical Center
DuBois, Pennsylvania, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Albert Einstein Medical Center; Division of Hepatology
Philadelphia, Pennsylvania, United States
Methodist Heathcare University Hospital
Memphis, Tennessee, United States
Imtiaz Alam MD, P.A. - Private Practice
Austin, Texas, United States
Methodist Transplant Physicians
Dallas, Texas, United States
Univ of Texas Medical Branch
Galveston, Texas, United States
Kelsey Research Foundation
Houston, Texas, United States
Liver Associates of Texas
Houston, Texas, United States
Digestive And Liver Disease Consultants, PA
Houston, Texas, United States
University of Vermont
Burlington, Vermont, United States
University of Virginia Health System: Gastroenterology at UVA
Charlottesville, Virginia, United States
Metropolitan Research
Fairfax, Virginia, United States
Fundacion de Investigacion de Diego
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML27900
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.